Partneringdesk Deals and Alliances In Metabolic Diseases

Partneringdesk deals and alliances in metabolic diseases provides an in-depth view of over 670 deals and alliances announced in metabolic diseases between 2001 and 2006, in a clear and accessible PDF format.

Reasons to purchase (USPs and key questions answered)
Partneringdesk Deals and alliances in metabolic diseases provides a comprehensive summary of the deals and alliances announced in the field between January 2001 and March 2006, and helps in:

• the assessment of deal-making trends in the last five years
• identifying active partners
• tracking competitor activity
• benchmarking deals

Partneringdesk deals and alliances in metabolic diseases brings all the relevant partnering deals into one place, providing a ready reference to deal making in metabolic diseases.

Report scope
The report contains:

• fully categorized deal overviews
• financial information where disclosed
• company profiles of the top 25 dealmakers in the report
• specialized indexes by company, development stage, deal type and industry sector.
• wider coverage of Japanese deals courtesy of JCN

Forecasts, projections, market estimates
This report provides a series of charts with analyses detailing market trends in metabolic diseases deal making over the period of 2001 to 2006.

Methodology
This report is derived from data obtained from Pharmalicensing’s Partneringdesk deals and alliances database. The database is updated daily using industry sources.